81 |
O fator de von Willebrand, ligação com fator VIII e estudo da atividade da ADAMTS-13 em pacientes com síndrome antifosfolípide primária / Study of von Willebrand factor activity, binding with factor VIII and ADAMTS-13 activity in patients with primary antiphospholipid syndromeNatalia Mastantuono Nascimento de Vita 09 December 2014 (has links)
A Síndrome Antifosfolípide (SAF) é uma doença autoimune na qual há presença de anticorpos antifosfolípides [anticoagulante lúpico (AL), anticardiolipina (ACL), anti-beta2glicoproteína I (a-beta2GPI)]. É caracterizada por eventos trombóticos e/ou perdas gestacionais de repetição. Existe um ambiente pró-coagulante na SAF, pois os antifosfolípides (AFL) são capazes de induzir disfunção endotelial aumentando a expressão de moléculas de adesão como o fator de von Willebrand (FVW). Entre os inúmeros elementos envolvidos neste processo, o FVW e a relação com: sua principal enzima proteolítica, a ADAMTS-13, e com o FVIII são relativamente menos conhecidos. Os objetivos deste estudo foram: 1-verificar alterações no endotélio de pacientes com SAF primária (SAFP), através do marcador de lesão endotelial, o FVW, da ADAMTS-13 e do FVIII, avaliando a concentração antigênica, a atividade e a correlação entre estas proteínas; 2- Verificar se alguma destas variáveis é capaz de diferenciar os tipos de eventos trombóticos ocorridos nestes pacientes e se a presença dos AFL influenciam estas proteínas. O estudo, do tipo transversal, envolveu 39 pacientes com SAF primária, com idade mediana de 43 anos, em tratamento no ambulatório de Reumatologia do Hospital das Clínicas, e 39 controles sadios doadores da Fundação Pró-Sangue Hemocentro de São Paulo, pareados por sexo e idade com os pacientes. Os títulos de ACL e a-beta2GPI, as determinações antigênicas e de atividade das proteínas FVW, ADAMTS-13, FVIII e PF4 foram realizados por ELISA, e a atividade do FVIII foi determinada pelo método cromogênico. A análise das subunidades do FVW foi realizada por Western immunoblotting. AL foi detectado utilizando ensaios de coagulação de acordo com as recomendações da Sociedade Internacional de Trombose e Hemostasia. Os resultados foram apresentados em: 1- pacientes SAFP e controles, e 2- pacientes SAFP agrupados em relação ao tipo de evento e ao tipo de AFL presente. Os pacientes apresentaram aumento da concentração antigênica do FVW (74±6 x 69±11 UI/dL; p=0,016), ADAMTS-13 (1,3±0,34 x 0,82±0,12 Ug/mL; p < 0,0001), FVIII (106±19 x 91±15 UI/dL; p=0,0003),da ligação FVW:FVIII (144±17 x 134±20%; p=0,082) e da atividade do FVIII (117±38 x 98±30%; p=0,0021) comparado aos controles. O PF4 apresentou-se diminuído nos pacientes em relação aos controles (96±12 x 101±8 UI/mL; p=0,014). Os pacientes com trombose arterial apresentaram correlação positiva e significante entre a atividade e o antígeno do FVW (r=0,468; p=0,028) e da ADAMTS-13 (r =0,635; p=0,001); os pacientes com trombose venosa apresentaram esta correlação positiva e significante na ADAMTS-13 (r=0,635; p=0,001). Quando os pacientes foram analisados pelo tipo de antifosfolípide, não se observou diferenças nas variáveis estudadas. Os pacientes com SAFP parecem apresentar disfunção endotelial. No entanto, aparentemente existe um mecanismo de equilíbrio para evitar a formação de um novo trombo. O papel do FVW e a sua relação com a ADAMTS-13, em diferentes doenças, ainda é relativamente pouco conhecido, mas está sendo apontado como importante na patogênese de estados pró-trombóticos como os presentes em pacientes com SAF / Antiphospholipid syndrome (APS) is an autoimmune disease, characterized by vascular thrombosis and /or pregnancy morbidity, in association with antiphospholipid antibodies (aPL) (lupus anticoagulant (LA), anticardiolipin (ACL), anti-beta2glicoprotein I (a-beta2GPI). Antiphospholipid (APL) seems to induce endothelial dysfunction by increasing the expression of adhesion molecules such as von Willebrand factor (VWF). This results in a prothrombotic state in APS. Among the several elements involved in this process, some are relatively less known, such as VWF and its relationship with ADAMTS-13, its main proteolytic enzyme. The aim of this study was to evaluate endothelial dysfunctions in patients with primary APS (PAPS), by examining correlation among the soluble endothelial marker, VWF, the enzyme ADAMTS-13, and FVIII protein. The relationship of these proteins and the presence of arterial and/or venous thrombosis, and presence of APL was also evaluated. This cross-sectional study involved 39 PAPS patients, with a median age of 43 years, who have been treated in the Outpatient Clinics, Department of Rheumatology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, and 39 healthy subjects blood donors from the Fundação Pró-Sangue Hemocentro de São Paulo, matched for sex and age with patients. Levels of APL (ACL and a-beta2GPI), concentration and activities of VWF, ADAMTS-13, FVIII and PF4 proteins were measured with ELISA. LA was detected with coagulation assays according to updated guidelines from the International Society on Thrombosis and Haemostasis, and FVIII activity was measured by chromogenic method. Analysis of VWF subunits was performed by Western immunoblotting. The results were evaluated according to:1- PAPS patients and controls, and2- PAPS patients grouped in relation to type of event and the type of APL. Patients showed higher VWF antigen concentration (74±6 x 69±11 IU/dL, p=0.016), ADAMTS-13 (1.3±0.34 x 0.82±0.12 Ug/mL, p < 0.0001), FVIII (106±19 x 91 ± 15 IU/dL, p=0.0003), VWF binding to FVIII (144±17 x 134 ± 20%, p=0.082) and activity of FVIII (117±38 x 98±30%, p=0.0021) than controls. The PF4 was decreased in patients compared to controls (96±12 vs. 101±8 IU/mL, p=0.014). VWF antigen and activity correlated well (Pearson´s r =0.468; p=0.028) as well as ADAMTS-13(Pearson´s r=0.635; p=0.001) in patients with arterial thrombosis. However, in patients with venous thrombosis only ADAMTS-13 had a good correlation (Pearson´s r =0.492; p=0.045). When patients were analyzed by the type of aPL, no differences in the studied variables were observed. Patients with PAPS seem to present endothelial dysfunction. However, apparently there is an attempt to balance mechanism to prevent a new thrombus formation. The role of VWF and its relation with ADAMTS-13 in different diseases is still relatively unknown. However it has been considered as important in the pathogenesis of prothrombotic states such as those present in patients with APS
|
82 |
Von Willlebrand Factor cleaving protease levels in patients with HIV related thrombocytopeniaGarizio, Dominique Gilda 11 February 2009 (has links)
Abstract
Background: Deficiency of Von Willebrand Factor Cleaving Protease (VWFCP) has been
implicated as the cause of Thrombotic Thrombocytopenic Purpura (TTP). TTP is a lifethreatening
disease characterised by microangiopathic thrombosis due to accumulation of
Ultralarge Von Willebrand Factor (ULVWF) multimers. The clinical features of TTP include
microangiopathic haemolysis and thrombocytopenia. TTP is being seen with increased
frequency in the context of HIV. However, in the context of HIV infection, cytopenias are often
multifactorial in nature and levels of VWFCP in HIV-related thrombocytopenia have not
specifically been assessed.
This study assessed VWFCP activity in the setting of patients with HIV and thrombocytopenia
in the absence of TTP, in order to determine the utility of a VWFCP assay in the diagnosis of
HIV-related TTP. Acquired VWFCP deficiency is generally assumed to be due to the
presence of autoantibody inhibitors to the enzyme, but limited data are available regarding
VWFCP activity in HIV positive TTP patients. There is also currently no assay available for
measuring VWFCP activity in our laboratory.
Aim of Study: To establish a practical assay for VWFCP activity for routine use in our
laboratory. The rapid collagen binding assay, based on the ELISA method of Rick, et al.,
2002, was chosen. This was initially used to measure VWFCP activity in patients with HIV
with and without thrombocytopenia (of any cause except TTP), in order to ascertain whether
assessment of VWFCP activity is likely to be of value in facilitating early diagnosis of HIV
related TTP.
The ELISA assay was performed to establish cut-off values for VWFCP in HIV negative
controls and two HIV positive groups (HIV thrombocytopenia / low platelets and HIV normal
platelets). Depending on the outcome of this, the assay could then be performed to assess
VWFCP activity in HIV positive patients with TTP.
Methods: The rapid collagen binding assay for VWFCP activity was established and
optimised for routine use in our laboratory. The cut-off values for percentage Residual
Collagen Binding Activity (RCBA) in both HIV negative and HIV positive groups were
identified. The assay could then be used to assess VWFCP activity in 20 HIV positive patients
with TTP at the time of presentation. In patients with reduced VWFCP activity, patient plasma
was mixed with normal pool plasma in a 50:50 mix, to assess for the presence of inhibitors.
Correlation of VWFCP activity, inhibitors and other laboratory and clinical parameters were
performed.
Results: The cut-off values for percentage RCBA in both HIV negative (<37.12%) and HIV
positive (<51.51%) patients were established. The % RCBA for the HIV negative control
group was statistically significantly different from the HIV positive group with normal platelets
(p=0.0001) and from the HIV positive group with low platelets (p=0.0006). The cut-off value in
the two HIV positive patient groups was higher than for HIV negative control patients,
indicating mildly reduced VWFCP enzyme activity in HIV positive patients (regardless of the
platelet count), in the absence of TTP. However, no significant difference in the cut-off value
was noted between HIV positive patients with low platelet counts versus HIV positive patients
with normal platelet counts (p=0.7783). The assay could therefore be used in HIV positive
patients with TTP.
VWFCP activity was assessed in twenty HIV positive patients with TTP. Two groups of HIV
positive patients with TTP were identified based on VWFCP activity. Six patients (30%) had
normal (one borderline) VWFCP activity (RCBA <51.51%), while the remaining 14 patients
had severely reduced VWFCP levels (RCBA >90%). Of the patients with reduced VWFCP
activity, only 5 patients had a detectable inhibitor, while an inhibitor was not detected in the
remaining 8 patients.
Conclusion: The rapid collagen binding ELISA assay is a cost effective semi-quantitative
assay for the assessment of VWFCP activity. VWFCP activity in HIV positive patients appears
to be slightly lower, however is not related to the platelet count. This suggests a slight
baseline deficiency of VWFCP in the setting of HIV. The baseline VWFCP cut-off value in HIV
allowed assessment of HIV positive patients with TTP. The results suggest heterogeneity of
VWFCP activity in HIV-related TTP. A negative result (normal VWFCP activity) does not
exclude TTP in patients with HIV-related TTP and other pathogenic factors may therefore be
involved.
|
83 |
Identification et expression d'anomalies moléculaires identifiées chez des patients atteints de la maladie de WillebrandArmbruster, Lysiane Mazurier, Joël. January 2003 (has links) (PDF)
Habilitation à diriger des recherches : Sciences naturelles : Lille 1 : 2003. / Synthèse de travaux en français avec articles en anglais reproduits dans le texte. N° d'ordre (Lille 1) : 398. Curriculum vitae. Bibliogr. p. 97-100. Liste des publications.
|
84 |
The mechanism of endothelial cell specific gene expression of Von Willebrand Factor in vivoNassiri, Marjan. January 2010 (has links)
Thesis (M.Sc.)--University of Alberta, 2009. / A thesis submitted to the Faculty of Graduate Studies and Research in partial fulfillment of the requirements for the degree of Master of Science in Experimental Medicine, Department of Medicine. Title from pdf file main screen (viewed on January 17, 2010). Includes bibliographical references.
|
85 |
Effects of Tetrastarch Administration on Hemostatic, Laboratory, and Hemodynamic Variables in Healthy Dogs and Dogs with Systemic InflammationGauthier, Vincent 05 September 2013 (has links)
Hydroxyethyl starches (HES) are the most routinely used synthetic colloids during fluid resuscitation and have reported effects on coagulation. The overall goal of the investigation in this thesis was to evaluate the effects of tetrastarch administration on hemodynamic, laboratory, and hemostatic variables in healthy dogs and dogs with systemic inflammation. The objectives were to compare hemodynamic and laboratory variables in dogs receiving an isotonic crystalloid (0.9% NaCl) or tetrastarch during health and after induction of systemic inflammation; to compare the hemostatic effects of an isotonic crystalloid (0.9% NaCl) and synthetic colloid (tetrastarch) in healthy dogs and dogs with induced systemic inflammation; to compare two different protocols for TEG® activation and to determine the correlation between TEG® variables and traditional coagulation test results.
Sixteen adult purpose-bred Beagles were randomized into one of two groups receiving fluid resuscitation with either 40 mL/kg IV isotonic crystalloid (0.9% NaCl) or synthetic colloid (tetrastarch) after administration of lipopolysaccharide (LPS; 5 μg/kg, IV) or an equal volume of placebo (0.9% NaCl, IV). Blood samples, for analysis, were collected at 0, 1, 2, 4, and 24 hours from the time of fluid resuscitation. After a 14-day washout period, the study was repeated such that dogs received the opposite treatment (LPS or placebo) and the same resuscitation fluid. Resuscitation with equal volumes of 0.9% NaCl and tetrastarch caused similar changes in hemodynamic and laboratory variables in dogs with LPS-induced systemic inflammation; however, larger increases in HR and blood pressure were seen within the first 2 hours following tetrastarch administration compared to 0.9% NaCl. Tetrastarch administration increased COP in all dogs, despite a decrease in TS. Tetrastarch bolus administration to dogs with LPS-induced systemic inflammation also resulted in a transient hypocoagulability characterized by a prolonged PTT, decreased clot formation speed and clot strength, and acquired type 1 von Willebrand disease.
Considering the limited additional benefit of tetrastarch administration on hemodynamic variables demonstrated, as well as the transient adverse hemostatic effects of tetrastarch administration, the increased cost associated with the use of tetrastarch likely negates its use as a first line treatment during fluid resuscitation in dogs. / Pet Trust Fund
|
86 |
Electron microscopic studies of helical polymersWang, Ying. January 2008 (has links)
Thesis (Ph. D.)--University of Virginia, 2008. / Title from title page. Includes bibliographical references. Also available online through Digital Dissertations.
|
87 |
Investigating the role of a novel ER molecular chaperone : Creld2 in the physiology and pathophysiology of endochondral bone growthEdwards, Sarah January 2015 (has links)
Cysteine rich with EGF-like domains 2 (Creld2) is a novel endoplasmic reticulum (ER) resident molecular chaperone that has been recently implicated in the ER stress signalling response (ERSS) and the unfolded protein response (UPR). Global transcriptomic data derived from in vivo mouse models of rare chondrodysplasias; Multiple Epiphyseal Dysplasia (MED Matn3 p.V194D) and Metaphyseal chondrodysplasia type Schmid (MCDS Col10a1 p.N617K), identified a significant upregulation in Creld2 expression in mutant chondrocytes. These chondrodysplasias share a common disease signature consisting of aberrant folding of a matrix component often as a result of inappropriate alignment of intramolecular disulphide bonds. This in turn culminates in toxic protein aggregation, intracellular retention mutant polypeptides and a classical ER stress response. The aim of this study was to further analyse the function of Creld2 in cartilage development and chondrodysplasias in which endochondral bone growth is perturbed. Protein disulphide isomerases (PDIAs) were amongst the most up-regulated genes in the MED and MCDS mouse models, consistent with the prolonged exposure of normally 'buried' cysteine residues. This led to the hypothesis that Creld2 was functioning as a novel PDI-like oxidoreductase to assist in the correct folding and maturation of aggregated misfolded polypeptide chains through REDOX regulated thiol disulphide exchange. A series of Creld2-CXXA substrate trapping mutants were generated in order to determine whether Creld2 possessed inherent isomerase activity. Here potential substrates interacting with Creld2 were 'trapped' as mixed disulphide intermediates, then isolated by immunoprecipitation and identified by mass spectrometry analysis. It was demonstrated that Creld2 possessed a catalytic active CXXC motif in its N-terminus that enabled the molecular chaperone to participate in REDOX regulated thiol disulphide exchange with at least 20 potential substrates including; laminin (alpha3,β3,γ2), thrombospondin 1, integrin alpha3 and type VI collagen. There was also numerous co-chaperones and foldases thought to be part of a specialised protein-protein interactome (PPI) for folding nascent polypeptides translocating the ER lumen. Moreover, co-immunoprecipitation experiments supported a protein-protein interaction between Creld2 and mutant matrilin-3, thereby inferring a potential chondro-protective role in resolving non-native disulphide bonded aggregates in MED. An established biochemical approach was employed to test the hypothesis that all MATN3-MED disease causing mutations have a generic cellular response to the β-sheet V194D mutation, consisting of intracellular retention, protein aggregation and ER stress induction. Several missense mutations were selected for analyses which encompassed a spectrum of disease severity and included examples of both β-sheet and alpha helical mutations. It was possible to define a reliable and reproducible assay for categorising MATN3 missense mutations into pathological or benign based on these basic parameters. This study was extended further to determine whether there were common pathological mechanisms behind MED and Bethlem myopathy (BM) caused by missense mutations in von Willebrand Factor A domain (vWF-A) containing proteins (matrilin-3 and type VI collagen respectively). We chose to compare and contrast the effects of an archetypal MATN3-MED causing mutation (R121W) with the equivalent COL6A2-BM causing mutation (R876H). These mutations compromised protein folding and maturation, resulting in the familiar disease profile of intracellular retention, protein aggregation and an ER stress response in an artificial overexpression system. However, the mutant C2 domain was efficiently targeted for degradation whilst mutant matrilin-3 vWF-A domain appeared to be resistant to these molecular processes.Molecular genetics was employed to study the role of Creld2 in vivo. Creld2-/- null mice (both global and conditional) were generated to directly examine the role of Creld2 in endochondral bone growth. Global knock-out mice were viable with no overt phenotype at birth. However, female Creld2-/- null mice showed a significant reduction in body weight and tibia bone length at 3 weeks of age. A cartilage specific knock-out was generated to determine whether these skeletal abnormalities were attributed to a systemic or a direct effect on cartilage development. [Creld2Flox/Flox Col2Cre (+)] demonstrated a severe chondrodysplasia with significantly reduced body weight and long bone growth compared to control littermates. Morphological and histochemical analysis of mutant growth plates revealed gross disorganisation of the chondrocyte columns with extensive regions of hypocellularity. These pathological features were confirmed to be the result of reduced chondrocyte proliferation and increased/spatially dysregulated apoptosis throughout all zones of differentiation. Taken together, these data provide evidence that Creld2 possesses isomerase activity and exhibits distinct substrate specificity. Furthermore, Creld2 has a fundamental role in post-natal cartilage development and chondrocyte differentiation in the growth plate.
|
88 |
Platelet Function in Dogs with Chronic Liver DiseaseWilkinson, Ashley R. 10 June 2019 (has links)
Background: Dogs with acquired chronic liver disease often have hemostatic derangements. It is currently unknown whether dogs with acquired chronic liver disease have decreased platelet function and alterations in von Willebrand factor (vWF) that may contribute to hemostatic abnormalities.
Hypothesis: Dogs with chronic liver disease have prolonged platelet closure time (CT), assessed with the PFA-100®, and buccal mucosal bleeding time (BMBT), and increased vWF concentration compared to healthy dogs.
Animals: Eighteen dogs with chronic acquired liver disease undergoing ultrasound-guided needle biopsy of the liver or laparoscopic liver biopsy and eighteen healthy age-matched control dogs.
Methods: Prospective study. BMBT, CT using the PFA-100®, and vWF antigen were measured in dogs with chronic liver enzyme elevation undergoing ultrasound-guided needle biopsy of the liver or laparoscopic liver biopsy. After undergoing ultrasound-guided needle biopsy, dogs were monitored for hemorrhage with serial packed cell volume measurements and focused assessment with sonography. An unpaired t-test was used for normally distributed data and the Mann-Whitney test was used when non-Gaussian distribution was present. The level of significance was set at P <0.05.
Results: The CT was not different between the two groups (P = 0.27). The BMBT was significantly longer in the liver disease group compared to the control group (P = 0.019). There was no difference in the mean vWF antigen of the two groups (P = 0.077).
Conclusions and clinical relevance: These results demonstrate mild impairment of primary hemostasis in dogs with chronic liver disease based on prolongation of BMBT. / Master of Science / Background: Dogs with chronic liver disease often have abnormal blood clotting activity. It is currently unknown whether dogs with chronic liver disease have decreased platelet function and alterations in von Willebrand factor (vWF) that may contribute to blood clotting abnormalities. Platelet function can be assessed using the PFA-100®, which measures platelet closure time (CT), and buccal mucosal bleeding time (BMBT). The PFA-100 simulates blood in circulation to assess platelet function. BMBT is a crude but readily available test to assess platelet function in practices without sophisticated methods of assessing platelet function.
Hypothesis: Dogs with chronic liver disease have prolonged CT and BMBT, which both suggest platelet dysfunction. Additionally, dogs with chronic liver disease have increased vWF concentration compared to healthy dogs.
Animals: Eighteen dogs with chronic acquired liver disease undergoing ultrasound-guided needle biopsy of the liver or laparoscopic liver biopsy and eighteen healthy age-matched control dogs.
Methods: Prospective study. BMBT, CT, and vWF antigen were measured in dogs with chronic liver disease undergoing ultrasound-guided needle biopsy of the liver or laparoscopic liver biopsy. After undergoing ultrasound-guided needle biopsy, dogs were monitored for hemorrhage.
Results: The CT was not different between the two groups but the BMBT was significantly longer in the liver disease group compared to healthy dogs. There was no difference in the mean vWF antigen between the two groups.
Conclusions and clinical relevance: These results demonstrate mild impairment of blood clotting activity in dogs with chronic liver disease based on prolongation of BMBT compared to healthy dogs. Prolongation of BMBT compared to healthy dogs is suggestive of endothelial dysfunction and/or platelet dysfunction in dogs with chronic liver disease.
|
89 |
Haemostatic markers and cardiovascular function in black and white South Africans : the SABPA study / Leandi LammertynLammertyn, Leandi January 2015 (has links)
Motivation
In the black population of South Africa, cardiovascular disease (CVD) is rapidly increasing due to
urbanisation. Stroke is usually accompanied by a prothrombotic haemostatic profile. Changing
lifestyle factors that accompany the urbanisation process could have a negative impact on the
haemostatic profile of black South Africans. Elevated levels of pro-coagulant factors, von
Willebrand factor (vWF), fibrinogen and fibrin D-dimer have been reported in the black population,
which could increase the black population’s susceptibility to CVD. However, low levels of
plasminogen activator inhibitor-1 (PAI-1) previously reported in the black population could
contribute towards a pro-fibrinolytic state, which may counteract the hypercoagulant state. This
may have a beneficial effect on the haemostatic profile of the black population. More investigation
into the haemostatic profile of black South Africans is therefore needed to determine if an altered
haemostatic profile exists in this group, and if so, to what extent these alterations may relate to
cardiovascular dysfunction. This study included markers of both the coagulation (vWF, fibrinogen,
fibrin D-dimer) and fibrinolytic (PAI-1, fibrin D-dimer and fibrinolytic potential) systems in an
attempt to investigate the haemostatic profile of the black population of South Africa, and for
comparison purposes that of the white population as well. The relationship of these markers’ with
selected markers of cardiovascular function was also examined to determine if they could possibly
contribute to an increase in cardiovascular risk, especially in the black population.
Aims
The aims of this study were to first compare coagulation and fibrinolysis markers in the black and
white populations of South Africa. Furthermore, to determine if associations exist between the
selected components of the haemostatic system and markers of cardiovascular function,
especially in the black population of South Africa, who tends to be at a higher cardiovascular risk
due to altered metabolic and haemostatic profiles.
Methodology
The Sympathetic activity and Ambulatory Blood Pressure in Africans (SABPA) study was a
prospective cohort study that consisted of 409 participants at baseline (2008-2009) that were
equally distributed according to both ethnicity (200 black; 209 white) and gender (black, 101 men,
99 women; white, 101 men, 108 women). At follow-up (2011/2012) the cohort totalled 359
participants (170 black, 88 men and 82 women; 189 white, 93 men and 96 women). Data from
baseline measurements were used for the first two manuscripts (chapters 2 and 3), while followup
data was used for the third manuscript (chapter 4). vWF, fibrinogen, PAI-1, fibrin D-dimer, CLT,
serum peroxides, glutathione, glutathione peroxidase and reductase activity were determined,
and ambulatory blood pressure and the retinal vessel calibres were measured. The groups were
stratified by ethnicity as specified by statistical interaction terms. T-tests and chi-square tests were
used to compare means and proportions, respectively. Pearson and partial regression analyses
were used to determine correlations between the components of the haemostatic system and
cardiovascular function markers. This was followed by multiple linear regression analyses to
investigate whether independent associations exist between the variables in both ethnic groups.
P-values ≤0.050 were deemed significant.
Results and conclusion of each manuscript
The first manuscript (chapter 2) compares the haemostatic profiles of the black and white
population to determine whether ambulatory blood pressure is related to components of the
haemostatic system. The black participants displayed a prothrombotic profile with significantly
higher vWF, fibrinogen, PAI-1, fibrin D-dimer and a longer CLT than their white counterparts.
Furthermore, partial and multiple linear regression analyses showed a positive association of
systolic and diastolic blood pressure with fibrin D-dimer in the black population, while a negative
association existed between ambulatory blood pressure and CLT in the white population. These
associations suggest that fibrin D-dimer may contribute, at least in part, to the high prevalence of
hypertension in the black population.
The second manuscript (chapter 3) determined associations between markers of the haemostatic
and oxidant-antioxidant systems in the black and white populations. In addition to the
prothrombotic profile that exists in the black population, this group also had significantly higher
serum peroxides (oxidative stress) and lower glutathione peroxidase activity (antioxidant) levels.
Multiple linear regression analyses indicated positive associations between fibrinogen and serum
peroxides in both populations. In the white population, an additional positive association was
found between serum peroxide and CLT. In the black population, vWF and CLT were negatively
associated with GPx activity. The results suggest that there are ethnic-specific relationships
between the haemostatic and oxidant-antioxidant systems.
The third manuscript (chapter 4) investigated the relationships between the retinal vessel calibres
and components of the haemostatic system in the black and white population. The investigation
focussed specifically on arteriolar diameters in the lower median, since a narrow arteriolar
diameter is known to be associated with elevated blood pressure. In both ethnic groups, a
narrower arteriolar calibre was accompanied by narrower venular calibres. Independent positive
associations were found between the central retinal vein equivalent (CRVE) and fibrinogen in the
black population, as well as vWF and CLT in the white population. In addition, independent
negative associations were found between the central retinal artery equivalent and CLT in the
black population and with vWF in the white population. The results suggest that haemostatic
alterations are linked to early vascular changes that may differ between ethnicities.
General conclusion
Ethnic-specific relationships between the components of the haemostatic system and measures
of cardiovascular function are evident. The prothrombotic profile that is observed in the black
population, together with the adverse associations of the haemostatic components with blood
pressure, a compromised oxidant-antioxidant profile, and retinal vessel calibres may contribute,
at least in part, to the high cardiovascular and cerebrovascular risk evident in this population
group. / PhD (Physiology), North-West University, Potchefstroom Campus, 2015
|
90 |
Haemostatic markers and cardiovascular function in black and white South Africans : the SABPA study / Leandi LammertynLammertyn, Leandi January 2015 (has links)
Motivation
In the black population of South Africa, cardiovascular disease (CVD) is rapidly increasing due to
urbanisation. Stroke is usually accompanied by a prothrombotic haemostatic profile. Changing
lifestyle factors that accompany the urbanisation process could have a negative impact on the
haemostatic profile of black South Africans. Elevated levels of pro-coagulant factors, von
Willebrand factor (vWF), fibrinogen and fibrin D-dimer have been reported in the black population,
which could increase the black population’s susceptibility to CVD. However, low levels of
plasminogen activator inhibitor-1 (PAI-1) previously reported in the black population could
contribute towards a pro-fibrinolytic state, which may counteract the hypercoagulant state. This
may have a beneficial effect on the haemostatic profile of the black population. More investigation
into the haemostatic profile of black South Africans is therefore needed to determine if an altered
haemostatic profile exists in this group, and if so, to what extent these alterations may relate to
cardiovascular dysfunction. This study included markers of both the coagulation (vWF, fibrinogen,
fibrin D-dimer) and fibrinolytic (PAI-1, fibrin D-dimer and fibrinolytic potential) systems in an
attempt to investigate the haemostatic profile of the black population of South Africa, and for
comparison purposes that of the white population as well. The relationship of these markers’ with
selected markers of cardiovascular function was also examined to determine if they could possibly
contribute to an increase in cardiovascular risk, especially in the black population.
Aims
The aims of this study were to first compare coagulation and fibrinolysis markers in the black and
white populations of South Africa. Furthermore, to determine if associations exist between the
selected components of the haemostatic system and markers of cardiovascular function,
especially in the black population of South Africa, who tends to be at a higher cardiovascular risk
due to altered metabolic and haemostatic profiles.
Methodology
The Sympathetic activity and Ambulatory Blood Pressure in Africans (SABPA) study was a
prospective cohort study that consisted of 409 participants at baseline (2008-2009) that were
equally distributed according to both ethnicity (200 black; 209 white) and gender (black, 101 men,
99 women; white, 101 men, 108 women). At follow-up (2011/2012) the cohort totalled 359
participants (170 black, 88 men and 82 women; 189 white, 93 men and 96 women). Data from
baseline measurements were used for the first two manuscripts (chapters 2 and 3), while followup
data was used for the third manuscript (chapter 4). vWF, fibrinogen, PAI-1, fibrin D-dimer, CLT,
serum peroxides, glutathione, glutathione peroxidase and reductase activity were determined,
and ambulatory blood pressure and the retinal vessel calibres were measured. The groups were
stratified by ethnicity as specified by statistical interaction terms. T-tests and chi-square tests were
used to compare means and proportions, respectively. Pearson and partial regression analyses
were used to determine correlations between the components of the haemostatic system and
cardiovascular function markers. This was followed by multiple linear regression analyses to
investigate whether independent associations exist between the variables in both ethnic groups.
P-values ≤0.050 were deemed significant.
Results and conclusion of each manuscript
The first manuscript (chapter 2) compares the haemostatic profiles of the black and white
population to determine whether ambulatory blood pressure is related to components of the
haemostatic system. The black participants displayed a prothrombotic profile with significantly
higher vWF, fibrinogen, PAI-1, fibrin D-dimer and a longer CLT than their white counterparts.
Furthermore, partial and multiple linear regression analyses showed a positive association of
systolic and diastolic blood pressure with fibrin D-dimer in the black population, while a negative
association existed between ambulatory blood pressure and CLT in the white population. These
associations suggest that fibrin D-dimer may contribute, at least in part, to the high prevalence of
hypertension in the black population.
The second manuscript (chapter 3) determined associations between markers of the haemostatic
and oxidant-antioxidant systems in the black and white populations. In addition to the
prothrombotic profile that exists in the black population, this group also had significantly higher
serum peroxides (oxidative stress) and lower glutathione peroxidase activity (antioxidant) levels.
Multiple linear regression analyses indicated positive associations between fibrinogen and serum
peroxides in both populations. In the white population, an additional positive association was
found between serum peroxide and CLT. In the black population, vWF and CLT were negatively
associated with GPx activity. The results suggest that there are ethnic-specific relationships
between the haemostatic and oxidant-antioxidant systems.
The third manuscript (chapter 4) investigated the relationships between the retinal vessel calibres
and components of the haemostatic system in the black and white population. The investigation
focussed specifically on arteriolar diameters in the lower median, since a narrow arteriolar
diameter is known to be associated with elevated blood pressure. In both ethnic groups, a
narrower arteriolar calibre was accompanied by narrower venular calibres. Independent positive
associations were found between the central retinal vein equivalent (CRVE) and fibrinogen in the
black population, as well as vWF and CLT in the white population. In addition, independent
negative associations were found between the central retinal artery equivalent and CLT in the
black population and with vWF in the white population. The results suggest that haemostatic
alterations are linked to early vascular changes that may differ between ethnicities.
General conclusion
Ethnic-specific relationships between the components of the haemostatic system and measures
of cardiovascular function are evident. The prothrombotic profile that is observed in the black
population, together with the adverse associations of the haemostatic components with blood
pressure, a compromised oxidant-antioxidant profile, and retinal vessel calibres may contribute,
at least in part, to the high cardiovascular and cerebrovascular risk evident in this population
group. / PhD (Physiology), North-West University, Potchefstroom Campus, 2015
|
Page generated in 0.0483 seconds